Delisting of IGEA Pharma N.V., Hoofddorp NL – Decision of the Appeals Board of SIX Group

Menu Schliessen

On 31 October 2023, the Appeals Board of SIX Group AG dismissed the appeal of IGEA Pharma N.V. against the decision of the Regulatory Board of SIX Group AG to delist all registered shares of IGEA Pharma N.V. (Swiss Security Number 41’217’478 / ISIN NL0012768675) with a nominal value of EUR 0.01 each listed on SIX Swiss Exchange AG pursuant to Art. 58 para. 1 ciph. 2 Listing Rules (LR) due to the issuer’s solvency being in serious doubt. By upholding the decision of the Regulatory Board, the Appeals Board confirmed the delisting and the 3 November 2023 as last trading day at SIX Swiss Exchange AG.

The deadline for filing an appeal against the decision of the Appeals Board currently is still running. Consequently, the formal delisting of IGEA Pharma N.V. will not take place until further notice.

The decision regarding the delisting of IGEA Pharma N.V. is available on the Website of SER.

The applicable directive is available at the following link.

If you have any questions, please contact
Hrvoje Tkalcec, Head Communications & Media Relations.
Phone: +41 58 399 2267
Email: ser_media@six-group.com

SIX Exchange Regulation AG is a legally independent company of SIX Group and of one the Regulatory bodies of the SIX trading venues. It performs the functions assigned under Swiss federal law and enforces the rules laid down by the Regulatory Board, and monitors compliance with legal and regulatory requirements. As part of its diverse remit, SIX Exchange Regulation AG submits proposals for sanctions to the Sanctions Commission or can enact sanction notices. SIX Exchange Regulation AG consists of the divisions Listing & Enforcement, responsible for regulating issuers, and Surveillance & Enforcement, which monitors trading.
www.ser-ag.com

SIX provides and operates stable and efficient infrastructure for the Swiss and Spanish financial centers, thus ensuring access to the capital markets and the flow of information and money between financial market players. As a global provider of financial information, SIX delivers high-quality reference, pricing, corporate actions, and ESG data and provides regulatory services and indices to clients around the world. The company is owned by its users (more than 120 banks) with a workforce of 4,160 employees and a presence in 19 countries.
www.six-group.com

Media Release

Delisting of IGEA Pharma N.V., Hoofddorp NL – Decision of the Appeals Board of SIX Group